On Medicare? Accessing CGMs Just Got Easier
A recent update to continuous glucose monitor (CGM) coverage requirements will make it easier for people covered by Medicare to…
Eli Lilly Acquires Breakthrough T1D T1D Fund Portfolio Company Protomer Technologies
Breakthrough T1D is excited to announce that the T1D Fund portfolio company Protomer Technologies, who is developing "smart" insulin, has been acquired by Eli…
Teplizumab (the Therapy that Delays T1D By Nearly 3 Years) Isn’t Approved…Yet
The FDA issued a letter to Provention Bio for the use of teplizumab to delay T1D in at-risk individuals, meaning…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage
There were a number of fantastic results at the ADA’s Scientific Sessions. Here is a video and a summary of…
Video: ADA’s Scientific Sessions: Day 4
Here is Dr. Camillo Ricordi to share his key takeaways from day 4 from the American Diabetes Association's Scientific Sessions.
ADA’s Scientific Sessions: Day 3
Here are Drs. Jennifer Sun, Dana Lewis, and Christine Wang to share their key takeaways from day 3, with their…
ADA’s Scientific Sessions: Day 2
Drs. Danny Chou, Peter Arvan, Jeffrey Millman, and Efsun Arda will share their key takeaways from day 2, with their…
ADA’s Scientific Sessions: Day 1
Here are Drs. Candace Reno and Luiza Caramori share their key takeaways from day 1, with their commentary in the…
Artificial Intelligence Identifies T1D Risk Factors in Children
Breakthrough T1D and IBM Research have published their first paper, applying world-class computing power to identify factors leading to the…
